Hopefully now a competition where everyone needs some and will keep buying while it keeps rising...FOMO |
I'm not an expert by any means but I maintain a keen interest in charts and in OXB (vested!). I mentioned a little while ago that I thought we were heading into a 'cup and handle' pattern and I do believe that's what's happening (I'm also relying on good old fashioned crossed fingers here!). If that is what is playing out, we might be looking at 760's as our next target. See here for an explanation: |
Something in the pipeline? |
Any chart experts here...if you glance at the 5 year chart there seems to be a next resistance around £5 from way back.
Harry you have repeatedly moaned what happened when we had the forced selling from 15 down to 2 from the IIs...perhaps we are now playing the reverse...if there are long term buy orders on the book in a thin market punters can push through an open door in the reverse of the last few years :) nai etc |
Lesley Nielsen comes to mind
Bursting through 400p is pleasant |
Surely 112k in the 1st 40mins can't just be down to that automated tip website? |
Looking good. |
That's £4 broken |
I like the words "can occasionally turn into an explosive long trade".
Let's hope this is one of those occasions! |
Signal Update - british bulls 18/10 went back long from short, a nasty bear trap for the shorters from 385p proven to have failed :)
Our system’s recommendation today is to BUY. The BULLISH STOP LOSS pattern finally received a confirmation because the prices crossed above the Stop Loss level which was at 392.50, and our valid average buying price stands now at 395.01. The previous SELL signal was issued on 15/10/2024, 3 days ago, when the stock price was 385.11. Since then OXB.L has risen by +2.57%.
Market Outlook
A rally after a bear setup can occasionally turn into an explosive long trade. We may be on the verge of catching one of them. There is now a strong positive sentiment in the market despite the absence of a bullish pattern.
I assume most folks treat bot trading tools with a healthy pinch of salt, I only post this as I think the wording of the second paragraph best sums up the mood that I see conveyed here as LTHs...nai of course... |
Strong bounce back to end the week. Enjoy the weekend all LTH's, look forward to seeing what happens Monday. |
 I find the current valuation quite frustrating.
Appreciate all the reasons / possibilities which got us here and have been done many times - i.e. end of the vaccine contract / post-covid economy recession / then inflation & interest rates against stocks / then Homology going west as a company worth c20m per year to us.
But, a much smaller OXB pre-covid was still worth at least 50% more than today and today's OXB has OXB France about to play a blinder with the Geovax vaccine contracts and OXB USA stabilised after losing the Homology sales and just abut made up ground in new AAV / LV work.
We should be laughing and at a minimum selling on the "boring" average of 5.5x the covering analyst's consensus sales for next year of £130m.
So, 5.5 x £130m = £715m mkt cap / 105.3m shares = 679p per share and as I say that would be a very average CDMO rating - not one weighted for pure CGT work.
I think they deserve it and if it doesn't happen this year then I'm certain it will be next. I just don't see (OXB observer badge and bar) how they hit £6 and us back in the FT250 without a very good RNS in the next 25 working days.
I'm sure there is big news due and I would bet a fiver that's the same reason why none of the insiders who could have bagged some very cheap shares have done so. The big question is when will they be allowed to tell the market.
On the bright side I think that we just ended this week on a 12 month high, so I will take that and say thank you. |
Harry, at least stand in the street and do the 5 minute clap for Frank if we close about 4...within nibbling distance...of course we get your wider point...but these 30 pence from 370 to 400 have been like getting blood out of a stone so fierce has been the resistance... |
I realise I'm in stuck record mode here, but I really do think it needs a very significant RNS from Frank sometime in the next 25 working days to get us back into the FT250 this year.
Maybe technicals alone can do it - if breaking through some barrier gets momentum traders in, which then gets other curious people looking at the fundamentals (particularly next year's guidance) but I think it needs a good RNS to be sure. |
DC...quoted 3.94 to buy very small amount :) |
Who knows Dom?
Would agree it is being controlled & certainly not a natural price by any stretch of the imagination.
Look forward to a trigger but not currently holding my breath |
385p seems to be the 'right' price atm, but wait until the close, eh? |
takeiteasy, yes, and you wonder who has the heft to say to the mms "take it down another 20 pence and I'll buy tens of thousands"? I can think of one candidate. |
Interesting Santar,
I have a memory of 888 cigarettes in motor racing but no idea if that was lucky number related. |
I don't subscribe, but one of these is OXB |
We my be luckier (breakout wise) this time as the traders have done the pull down only to be met with net buyers....so they are not sitting on the fence think a quick short might get them pile of cheaper shares...let's see....not often you see a market try this hard to keep a lid on :) |
It's also four fat ladies. I'll ask Mystic meg. |
Harry, that's auspicious. 8 in Thai is baht - which also means money (Thai Baht), so that is a very lucky number - money money money money! |
PB,
I would imagine that the politics of rival weight loss drugs is hovering there.
Novo wanted security of supply to meet demand for their first to market weight loss drug which was touted to become the most lucrative prescribed drug of all time. There are other GLP1 drugs out there / nearly there now and if there is a US candidate then that will not be lost on US politicians.
We would never have made the weight loss drug (it's not what we do or have the capability / facilities to do). |
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Hot Features
Premium
